Latest News
Latest News moreAmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for RET fusion-positive non-small cell lung cancer (“NSCLC”), for selpercatinib capsules 40 mg
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
Say hello to us at booth 1220 and learn more about our companion diagnostic solutions.
Career Opportunities - The Field Application Scientist
The Field Application Scientist is responsible for system usage training at customer sites while providing PCR/NGS experimental design, data analysis, logistical, and troubleshooting support for LATAM.
Career Opportunities - Business Manager (EMEA)
You are looking for opportunities to bring to use your knowledge of and experience in oncology molecular diagnostics in qPCR and Next Generation Sequencing application? You are passionate in building meaningful relationship with both internal and external
- 27 /Mar AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
- 24 /Mar AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
- 25 /Nov Career Opportunities - The Field Application Scientist
- 25 /Nov Career Opportunities - Business Manager (EMEA)
New Products
new product release-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
New Products
new product release-
NGS
-
PCR
-
FISH
-
Extraction
- Customer Service
- FAQS
- DOWNLOAD
ESMO Asia
https://www.esmo.org/meetings/esmo-asia-congress-2022
December 2-4, 2022AMP
https://www.amp.org/events/amp-events-calendar/calendar/amp-2022-annual-meeting-expo/
November 3-5, 2022-
Stock Info
Stock info -
0 0％Stock code：300685 Real-time data
- View details
